ASH 注册研究提供血液系统恶性肿瘤患者 COVID-19 相关信息。
ASH Registry Offers Insights on COVID-19 in Patients with Hematologic Malignancies.
出版信息
Oncologist. 2021 Feb;26 Suppl 1(Suppl 1):S17-S18. doi: 10.1002/onco.13657. Epub 2020 Dec 28.
Abstract
For patients with blood cancers, the COVID‐19 mortality rate is approximately 20% overall and 33% for those who require hospitalization, according to new data from the ASH Research Collaborative COVID‐19 Registry for Hematology.
摘要
根据 ASH 研究协作 COVID-19 血液学登记处的数据，对于血液癌症患者，COVID-19 的总体死亡率约为 20%，需要住院治疗的患者死亡率约为 33%。
Zotero 插件